Peers for comparison
Key facts today
Barclays maintained its Overweight rating on Ligand Pharmaceuticals Incorporated (LGND) and raised its price target to $350 from $345. 1
2.59 USD
124.45 M USD
268.09 M USD
19.52 M
Last report date
Report period
EPS
Revenue
Earnings release details
Q3 royalty revenue grew 51% YoY, and adjusted EPS guidance rose to $9.50-$9.75. The expanded portfolio includes more than 200 royalty assets, with up to seven pivotal readouts expected through 2027.
Company info
Sector
Industry
CEO
Todd Christopher Davis
Website
Headquarters
Jupiter
Founded
1987
IPO date
Nov 18, 1992
ISIN
US53220K5048
CUSIP
53220K504
FIGI
BBG000BKF014
Identifiers
ISIN US53220K5048
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Stocks To Watch This WeekThe Bull Market is strong, the end of 2020 saw many growth names pull in or consolidate which gives a better reward to risk entry. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names are at or near all time highs or multi year highs. There a
LGND. Consolidation and preparing for grow up.#LGND. The share has been in consolidation for a month now in the range of 108-118. EMA50 is preparing to pass EMA100 from bottom to top on the daily chart, which will be a strong enough signal to buy. If out of the range, the growth can be explosive, as Short Float is 58.36% Possible TP levels are
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateSep 15, 2031
Coupon0% (Zero)
Maturity dateOct 1, 2030
Coupon0.75% (Fixed)
See all LGND bonds
Frequently asked questions
Today, LGND trades at 316.83 USD.
For broader market analysis, dive into the technicals on the Ligand Pharmaceuticals Incorporated stock price chart and read the latest LGND news:
– Ligand Pharmaceuticals Is Maintained at Overweight by Barclays
– Barclays maintains Ligand Pharmaceuticals at Overweight, raises price target to $350 from $345
– Ligand Pharmaceuticals Is Maintained at Buy by Citigroup
For broader market analysis, dive into the technicals on the Ligand Pharmaceuticals Incorporated stock price chart and read the latest LGND news:
– Ligand Pharmaceuticals Is Maintained at Overweight by Barclays
– Barclays maintains Ligand Pharmaceuticals at Overweight, raises price target to $350 from $345
– Ligand Pharmaceuticals Is Maintained at Buy by Citigroup
Markets don't sleep, here's what's going on with LGND at the moment:
– Ligand Pharmaceuticals Is Maintained at Overweight by Barclays
– Barclays maintains Ligand Pharmaceuticals at Overweight, raises price target to $350 from $345
– Ligand Pharmaceuticals Is Maintained at Buy by Citigroup
See more updates in real-time with our News Flow.
– Ligand Pharmaceuticals Is Maintained at Overweight by Barclays
– Barclays maintains Ligand Pharmaceuticals at Overweight, raises price target to $350 from $345
– Ligand Pharmaceuticals Is Maintained at Buy by Citigroup
See more updates in real-time with our News Flow.
Ligand Pharmaceuticals Incorporated is scheduled to release its next earnings report on Mar 4, 2027.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
LGND stock is 2.63% volatile and has beta coefficient of 0.81.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like LGND are typically less volatile than smaller companies
Track every detail on Ligand Pharmaceuticals Incorporated stock chart and check out the list of the most volatile stocks — is Ligand Pharmaceuticals Incorporated there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like LGND are typically less volatile than smaller companies
Track every detail on Ligand Pharmaceuticals Incorporated stock chart and check out the list of the most volatile stocks — is Ligand Pharmaceuticals Incorporated there?
To understand the LGND stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +0.85%
– 1 week — −0.68%
– 1 month — +4.74%
LGND all-time low was 6.60 USD (Oct 28, 2008), and its highest price is 326.63 USD (Jul 8, 2026). Find more dynamics in the Stock Heatmap and on the Ligand Pharmaceuticals Incorporated stock chart.
– 1 day — +0.85%
– 1 week — −0.68%
– 1 month — +4.74%
LGND all-time low was 6.60 USD (Oct 28, 2008), and its highest price is 326.63 USD (Jul 8, 2026). Find more dynamics in the Stock Heatmap and on the Ligand Pharmaceuticals Incorporated stock chart.
Ligand Pharmaceuticals Incorporated market capitalization is 6.28 B, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Ligand Pharmaceuticals Incorporated stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Ligand Pharmaceuticals Incorporated stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Ligand Pharmaceuticals Incorporated stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Ligand Pharmaceuticals Incorporated stacks up against other companies
The safest way to buy Ligand Pharmaceuticals Incorporated stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade LGND directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade LGND directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 12, 2026, the company has 47 employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Investing in Ligand Pharmaceuticals Incorporated depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study Ligand Pharmaceuticals Incorporated financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our LGND technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
First, study Ligand Pharmaceuticals Incorporated financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our LGND technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
Ligand Pharmaceuticals Incorporated stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Ligand Pharmaceuticals Incorporated stocks trade under the symbol LGND.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
LGND earnings for the last quarter are 2.67 USD per share, whereas the estimation was 2.33 USD, resulting in a 14.66% surprise. The estimated earnings for the next quarter are 2.88 USD per share.
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in Ligand Pharmaceuticals Incorporated financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in Ligand Pharmaceuticals Incorporated financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Ligand Pharmaceuticals Incorporated revenue for the last quarter amounts to 78.75 M USD despite the estimated figure of 77.00 M USD. In the next quarter revenue is expected to reach 97.80 M USD.
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in Ligand Pharmaceuticals Incorporated financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in Ligand Pharmaceuticals Incorporated financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track Ligand Pharmaceuticals Incorporated financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
LGND net income for the last quarter is −28.48 M USD, while the quarter before that showed 48.51 M USD of net income which accounts for −158.72% change.
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Ligand Pharmaceuticals Incorporated financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Ligand Pharmaceuticals Incorporated financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Ligand Pharmaceuticals Incorporated does not currently pay dividends to its shareholders.
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
LGND reached its all-time high of 326.63 USD on Jul 8, 2026. Its all-time low was 6.60 USD and was reached on Oct 28, 2008.
Explore the Ligand Pharmaceuticals Incorporated stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the Ligand Pharmaceuticals Incorporated stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Ligand Pharmaceuticals Incorporated EBITDA is 73.48 M USD, with an EBITDA margin of 30.18%.
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Ligand Pharmaceuticals Incorporated statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Ligand Pharmaceuticals Incorporated statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 335.00 USD and 406.00 USD for LGND, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance









